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The viruses of influenza are notable for the extent of antigenic variation which 
they display, not only with experimental manipulation, but also under natural 
conditions from epidemic to epidemic and within epidemics. Although all in- 
fluenza A viruses are immunologically  related they are not antigenically identi- 
cal, as shown by the fact that antibodies against a  given strain may be less 
effective against heterologous than homologous viruses. Reciprocal cross-tests 
on viruses and their antisera have yielded a wealth of data, showing that both 
large and small antigenic difference  occur even with strains isolated in the 
same epidemic. In these cross-tests w.th many strains, there is usually no clear 
indication of an orderly arrangement of virus subtypes, but rather one gains 
the impression of an infinite variety of antigenic patterns with exceedingly com- 
plex interrelationships. This view is fortified by the somewhat conflicting at- 
tempts at compression of influenza A strains into broad groupings (1-3). 
Very probably, the surface of a virus is made up of a  number of antigenic 
groups, each of which may undergo variation and it seems unlikely that more 
definite conclusions regarding these variations can be reached by further tests 
done with intact viruses and antisera prepared against whole organisms. One 
obvious way of studying the antigenic composition of influenza viruses is by 
absorption of antisera with heterologous strains. That this has not already been 
done extensively is doubtless due in part  to  technical difficulties and to the 
large amounts of virus that are necessary. 
When a strain difference exists between viruses there are two principal mecha- 
nisms by which it may be explained: (1)  the same antigens may be present in 
both agents but in different proportions or (2) each virus may contain antigenic 
components which are not present in the other. The first attempts to distinguish 
between quantitative and qualitative antigenic variation were made by Frlede- 
wald (4) who used absorbed sera, and his results strongly indicated that there 
were strain-specific elements in some of the viruses he examined. However, no 
further experiments have been published since 1944 confirming or expanding his 
results, either through the use of more extensive absorption procedures or by 
the examination of a larger array of strains. 
In the work reported below, serum absorption was applied on a wide scale to 
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the examination of influenza viruses which were isolated from man over an  18 
year period.  The results permit a  distinction to be made between quantitative 
and  qualitative antigenic  variation  and  furthermore  suggest  that  this  distinc- 
tion may be of considerable  importance  in various aspects  of the study  of in- 
fluenza.  The  use  of  absorbed  sera  permits  the  subdivision  of  the  influenza A 
group into antigenic  types and,  while the separation of such types is at present 
very incomplete, the present data offer a  clear basis for future studies of obvious 
interest. 
Materials and Methods 
Virus Strains.--Ten influenza A  strains  were selected for intensive study:  Swine (Sw), 
WS, PR8, Melbourne (Mel), Gatenby (Gat),  Christie (Chr), Talmey (Tal), Ala-41,  NY-43, 
and FM-1. All except the last were obtained from the Laboratories of the International Health 
Division of The Rockefeller Foundation in New York City in 1945 and have been  used by 
the author in previous studies. The FM-1 strain was obtained from Dr. J'. E..Smadel of the 
Army Medical School, Washington, D. C. All these strains had  been adapted to growth in the 
allantoic sac and  allantoic fluid virus was used for the production of antisera in rabbits,  for 
the absorption of antibodies from immune sera and for the  testing of HI (hemagglutination 
inhibition) titer of immune sera. Many other strains (listed in Table I) were used in HI tests 
with absorbed sera. These were obtained mainly through the kindness of Dr. T. P. Magill and 
were part of his collection at the Strain Study Center. 
Virus Preparations.--Virus used for serological  testing was prepared in the usual way  by 
inoculating a  10  -5 dilution into the allantoic sac of 11-day old chick embryos and harvesting 
the allantoic fluid after 48 hours at 36°C. and  16 hours  at 4°C.  These  fluids were dialyzed 
against buffered saline and stored at 40C. The same preparations were used for the immuni- 
zation of rabbits. Virus used  for antibody absorption  was  removed from allantoic fluid by 
centrifuging at 13,000 l~.r.M, for 90 minutes in an  angle centrifuge and was resuspended  in 
saline of 1/100 the original volume. This was used without further purification. 
Preparation of Antioera.--All  antisera were prepared in rabbits.  The animals were given 
one intravenous  injection of 10 ml. of dialyzed allantoic fluid virus and were bled from an ear 
vein 2 weeks later. A second injection of 10 ml. of virus was given intraperitoneally and another 
bleeding taken after 8 to 14 days. Intraperitoneal inoculation and bleeding were repeated after 
rest intervals. 
Testing of Antisera.--All  sera  were treated  with  RDE  (receptor  destroying enzyme of 
Vibrio Cholerae) before testing. RDE was used in a  concentration sufficient  to remove any 
non-specific inhibition in an HI test at a final serum dilution of 1 : 16 with any of the ten virus 
strains. All tests for antibody were made with the HI test. Falling twofold dilutions of sera 
(0.25 ml.) were combined with virus (0.23 ml.) of such strength that the final hemagglutination 
titer was four units. Fowl red cells (0.5 per cent in saline)  were added (0.5 ml.) and the sedi- 
mentation pattern  read after 45 minutes at room temperature.  The sedimentation patterns 
were read as  +,  -% or negative, meaning full, partial, or absence of  agglutination. Partial 
inhibition was taken as the end-point and titers are expressed  throughout as the reciprocal 
of the final serum dilution. 
Preparation of RDE.--The Inaba  (National Institutes of Health Strain 35A3)  or the 42; 
(5)  strain of V. chderae was grown in peptone broth for 18 hours.  CaCI~ was added to the 
culture and the pH adjusted to 6.0 with HC1 according to the method of Stone (6). Mter heat- 
ing at 56°C. for 30 minutes the sediment was removed and the supernatant was concentrated 
50 to 100 times by pervaporation through cellophane and then dialyzed against saline.  The 
ability of different preparations to remove Mel receptors from red cells was quite variable, but 
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Absorption of Antisera with Viruses.--The  technique used  for antibody  absorption  was 
essentially similar to that of Walker and Horsfail (7). The sera were diluted 1:3 with saline 
and RDE was added, 0.1 ml. of RDE concentrate per ml. of undiluted serum. Mter 2 hours' 
incubation at 37°C., antibody absorption was carried out by adding the virus in a  series of 
steps. At each stage, the absorbing virus, concentrated 100 times, was added to the serum in a 
ratio of 1 part virus to 2 parts undiluted serum. Mter standing overnight at 4°C., the virus was 
largely removed by centrifugation at 13,000 l~.P.~, in an angle head for 90 minutes. Usually 
several such absorptions were carried out serially after which sodium citrate was added to a 
final concentration of 2 per cent and the serum heated at 65°C. for 30 minutes. Heating at this 
temperature nearly always destroyed any residual hemagglutinin left after centrifugation and 
did not detectably destroy antibody.  No antiserum was diluted beyond  1:4 and  after this 
dilution was reached through the addition of virus, further absorptions were carried out by 
adding the virus in the form of a pellet which was resuspended with the aid of a TenBroeck 
grinder. It proved necessary to remove the bulk of the absorbing virus before heating, since 
it was found that virus released absorbed antibody at 65°C. 
It happened very often that immune rabbit  sera were found to contain hemagglutinins ac- 
tive against chicken cells at dilutions of 1:256 or less.  This was especially true of sera from 
animals that had received long courses  of immunization and was presumably  the result of 
inoculation of chick embryo material along with the  virus. These hemagglutinins interfered 
with the specificity of the HI tests at  low dilutions. They could be removed with fowl red 
cells but it was found that they disappeared during the process of antibody absorption, again 
presumably owing to chick embryo impurities in the absorbing virus. 
EXPERIT~I~.NTAL 
Selection  of Strains for Antigenic Comparison 
Since one of the principal  objectives of this work was  to determine whether 
there  are  strain-specific  antigens  among  the  influenza  A  group,  viruses  were 
chosen  for  special  study  which  had  been  shown  to  differ  sharply  from  each 
other by the usual methods of cross-testing.  In addition,  an attempt was  made 
to include in the test strains from most of the major outbreaks  since  1933.  In 
order to minimize the difficulties of cross-testing,  the number  of strains  inten- 
sively studied  was  limited  to  ten  and  this  resulted  in  some  omissions  which 
will have to be corrected in future work. 
The strains chosen were as follows: WS (8), PR8 (9), and Mel (10) were the three earliest 
strains used, dating from epidemics in 1933, 1934, and  1935. They are widely employed for 
experimental work and in this laboratory show marked differences from one another. Strains 
Chr, Tai, and  Gat were  obtained from the English epidemic of 1936--37 and were used by 
Smith and Andrewes as the representative type strains of that outbreak (2). Ala-41 and NY-43 
are the author's strains from American epidemics of 1941 and  1943 and are included because 
of previous antigenic studies on them (11, 12) which showed that each was fairly representative 
of  the strains then current.  Strain FM-1 is the most widely used representative of the kind 
of virus which was prevalent in 1946 and in subsequent years. The Sw strain was isolated in 
1932 by Dr. R. E. Shope and is sometimes designated as Swine-15.  Of the foregoing strains 
only Ala-41  and NY-43 have been shown by previous tests to resemble one another closely. 
The rest have been considered by most investigators to be widely divergent from each other. 
A  number of rabbits  were immunized with each of the foregoing strains and  sera were 
selected for absorption  on the basis of the highest HI titer against  the homologous virus. 
This was usually in the range of 4,000 to 16,000. Extensive preliminary tests were carried out TABLE  I 
HI Tests u4th Influenza A  Viruses Done wi~h Absorbed S~ra of Seven Virus  Types 
Strain  Year 
So.  designation  isolated 
1  WS  1933 
2  PR8  1934 
3  Melbourne  1935 
Place  Isolated 
isolated  by 
England  (2) 
Puerto Rico  (1) 
Australia  (1,  10) 
4 
5 
6 
7 
8 
9 
10 
I1 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
23 
26 
27 
28 
29 
Philadelphia  1934--35  U.S.A. 
Alaska 313  1935  Alaska 
Miss.--4, 5  1935-36  NYC 
Talmey  1937  England 
Gatenby  1937  England 
Christie  1937  England 
0akham  1937  England 
Letchworth  1937  New York 
Patnode  1937  NYC 
Henry  1936-37  NYC 
BH  1935  England 
NY-2  1936  NYC 
TF  1936-37  NYC 
Reid-A  1939  Australia 
Baum  1940-41  NYC 
Coyle  1940-41  NYC 
Kil-E  1940--41  Miss. 
Ala-41-E  1940--41  Ala. 
Ala-41-M  1940-41  Aa. 
BeI-A  1942  Australia 
Hemsbury  1943--44 London 
Lienhart  1943-44  Calif. 
Weiss  1943-44  Mich. 
L987  1943--44  NYC 
L999  1943-44  NYC 
L1004  1943-44  NYC 
Meth- 
od 
Strains tested against types 
(i) 
(1) 
(I) 
(2) 
(2) 
(2) 
(2) 
(13) 
(I) 
(i) 
(2) 
(13) 
(i) 
(14) 
T. Francis, Jr.  FME 
Magill and  FME 
Sugg 
(15)  E 
(15)  E 
(15)  FME 
(16)  E 
(17)  FME 
Eaton  E 
(18)  FME 
Hirst  E 
Hirst  E 
Hirst  E 
PR8  Sw  WS  Mel  Tal  A4~11" FM 
FME  --  400O 
FME 
FME 
FME 
FME 
FME  --  -- 
FME 
FME 
FME 
FME 
FME 
FME  --  -- 
FME 
FME 
?ME 
2000 
2000 
1000 
--  256 
--  256 
2000 
2000 
2000  -- 
1500  -- 
512  -- 
256  i  256  -- 
i 
2000 
FME  --  -- 
FME  64  -- 
2000  -- 
1000  -- 
1000  -- 
256  -- 
128  -- 
128  -- 
I 
--  512  -- 
256  -- 
! 
2000  -- 
512  -- 
1000  -- 
1000  -- 
-- indicates no inhibition with 4 units of virus and a  final serum dilution of 1:16. 
A majority of the references indicates papers in which the strain in question was studied and not necessarily 
a  paper referring to the isolation  of a  strain. 
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designation 
30  L1225 
31  CAM 
32  IAN 
33  FM-I 
34  Georgia 
35  Ch-F 
36  Skopp 
37  LF-47 
38  L2-47 
39  L3-47 
40  L7-47 
41  L8-47 
42  Jotz 
43  AZ 
44  Smith 
45  Moore 
46  Ocean Isl. 
47  Wilfong 
48  Devore 
49  Augustine 
50  Conn. 
51  L4-49 
52  A-Nederl.-49 
53  Albany-50 
54  Warren 
55  Sweden 3/50 
56  Eng. 1/51 
57  Saunders 
58  FM  111/51 
59  L590 
60  L615 
61  L629 
TABLE I~Conduded 
Year  Place 
solated I  isolated 
1943-44 
1946 
1945-46 
1947 
1947 
1947 
1947 
1947 
1947 
1947 
1947 
1947 
1947--48 
1948 
1947 
1947--48 
1947-48 
1948 
1948 
1949-50 
1949 
1949 
1949 
1950 
1949-50 
1950 
1951 
1951 
1951 
1951 
1951 
1951 
Isolated 
by 
NYC  Hirst 
Australia  (16) 
Australia  (16) 
N.J.  (19) 
Ga.  Friedewald 
Wyo.  Smadel 
Calif. 
Calif.  Smadel 
Penn.  Sigel (20) 
Penn.  (20) 
Penn.  (20) 
Penn.  (20) 
NYC  Magill 
NYC  Horsfall 
Cleveland  Feller 
Calif.  Lennette 
Ocean  Isl.  (21) 
Calif.  (22) 
New York  Gordon 
Pittsburgh  Salk 
Conn.  Green 
Philadelphia  Sigel 
Netherlands  Mulder 
New York  Gordon 
Wyo.  Gould 
Sweden  (23) 
England  (23) 
NYC  Eddy 
N.J.  Hilleman 
NYC  Hirst 
NYC  Hirst 
NYC  Hirst 
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Strains  tested  against  types 
~M- 
I 
16 
256 
256 
4O0 
400 
256 
256 
256 
128 
9O 
I000 
128 
256 
256 
256 
64 
64 
64 
64 
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with various sera, using a number of viruses for absorption and testing for the removal of ho- 
mologous and heterologous antibody. 
Serum 
Absorbed 
with 
I  Nil 
Z  PR8  3X 
3  PRO  2X 
4  PR8  2X 
5  Chr 
6  Got 
Test  Virus 
Sw  WS  PRO  Mel  Got  Chr  1"ol  AIo  NY  FMI 
i  i  I  I  I,,  m:  . 1  IG~ 
,~ooo  r  J.,H,  ["l  r--,  .~ 
"°°°t  r~  r'  m  ~  •  I 
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.oo%  ,I,,I,  r".  ["~  r "'~  :1 
'°°°t  ,"~  r7  il  iml  ';..l 
I0001-.~  i  l  1  m  m  m  f'--~  .-  r--  4 
I  '  i  ,  t  t  ,  i  i  I  i 
'  '  i  '  '  '  '  :I  f"~  ~~  ~  ,,-: 
"°co  f  r-i 
I00  r'7  i 
"if! 
IsOOOl: 
I000  r'7 
16000 
4°°c  I  r  "7 
IOOC  r'- 
IE  i  i 
,|  [1  ' 
i  i 
ii 
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I  1 
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''  i 
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"i 
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,  1 
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:  1 
1  t 
1 
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•  r'"~  I  1  ~I  [],,  [7 
t  j  i 
"  i:  il  ;:  ,,  F7 
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i  ,  i 
I  ,  ,  ~  ! 
'  '  I  '  ;'7  ,  ,  ,  i 
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~~'  n  [] 
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;  i  i~  t, 
FIG.  1.  Absorption of Mel serum with PR8 virus. The solid areas indicate the HI titer 
against the various viruses at several stages of absorption. The dotted lines indicate the titers 
of unabsorbed sera.  The serum shown in line 4 was absorbed with Chr (line 5) and with Gat 
(line 6). 
Preliminary Absorption Tests with 1936-37 Strains 
Results are given below of cross-absorption tests between the English strains 
Mel, Gat, and  Chr. These are given in some detail since they clearly illustrate 
the  relationships  found  on  a  larger  scale. 
The experiment shown in Fig. 1 was carried out with a Mel serum and the 1st line shows 
the unabsorbed  titers against homologous and heterologous strains.  The titers against Mel, 
Gat, and Chr were 16,000, the titer against FM-1 was 64, the other values being intermediate. GEORGE K. HLRST  595 
The serum was absorbed three times with concentrated PR8 virus and retested for HI titer 
against the ten standard strains. The results, shown in the second line, indicate that antibody 
directed against five of the ten viruses was removed below the limit of detectability. However, 
a high level of antibody remained against strains Mel, Cat, and Chr; reactivity with Sw was 
only slightly diminished and  the titer against WS dropped  from 4,000  to  128. Two further 
absorptions with PR8 virus reduced the titer against Sw and WS still more but in all seven 
absorptions were necessary to take out these crossing antibodies completely. The serum, as 
shown in line 4, had a titer of less than 16 against seven strains but a titer of 2,000 against 
Mel, Gat, and Chr. At this stage, the serum was absorbed separately with heterologous strains 
Test  Viruses 
Serum 
Absorbed  Sw  W  S  PR8  Mel  Got  Chr  1"ol  AIo  NY 
with  8ooo 
I  Nil  e~ 
2  PR8  3X  "~'  "~  ~  t 
3"Z'  '~  :: 
eOOOr  I1___  ___  ~ 
3 PR8 2X  Zl°~lzl~I  ~,  .,If'i  1 
8000 
I  ..r.  ,  ,  1 
; ;  , :  2000  r- l  "";  ,"" II  ' 
"  ""  -  !i  ' 
,-  r  l  i  I  ,'  '  ]  !  i'~ 
I  ,  ~  , 
5  Gm 
[--1  J  f  i 
i 
I-; 
r .J'.~  [--~ 
!ii  i 
,i  •  ~'~  ~"~  ~  1  ':  if  i;  i  I 
FIG. 2.  Absorption of Chr serum with PR8. See Fig. l. 
Gat and Chr (lines 5 and 6). Each removed all of the detectable antibody remaining. Though 
not shown here the absorption of this Mel serum with Mel virus also removed all antibody. 
A similar series of absorptions of serum Chr is shown in Fig. 2. In this case, three absorp- 
tions with PR8 left antibody active against strains Ala-41,  NY-43, and Tal, as well as higher 
levels against Mel, Gat, and Chr. Two further  absorptions  left only antibodies  against  the 
latter three viruses, just as occurred in the previous experiment. Here, again, absorption with 
heterologous strain Mel removed all antibody while a single absorption with Gat left only a 
trace of Chr antibody. This was easily elimiuated in a further absorption. A similar series of 
tests was carried out with serum Gat. After thorough absorption with PR8 virus antibodies 
remained only for Mel, Cat, and Chr and these in turn were removed by any of these three 
viruses. 
The results of  the  foregoing  tests  were  given  in  some  detail  because  they 
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quantitative differences in the antigenic pattern and those due to sharp qualita- 
tive differences in the antigens present.  The group Mel, Gat, and Chr is an ex- 
ample of quantitative antigenic difference. Previous  studies  on these strains 
(1, 2) have shown that they are different from each other. The fact that absorb- 
tion of antisera for these three viruses with other strains always left antibody 
in high titer for these  viruses  and that each of these strains was capable  of 
completely removing antibodies against the others, suggests that Mel, Gat, and 
Chr belong in the same category or type of influenza A strains.  There is no 
evidence that any one of the three possesses an antigen which the others lack 
and hence it may be reasonable to assume that the antigenic differences among 
them are due to quantitative variations in the antigens present.  Some evidence 
in this direction is the fact that the initial absorption of Mel serum with PR8 
virus repeatedly left Sw and WS antibody which was very difficult to remove, 
while a similar absorption of Chr serum left Ala-41, NY-43, and Tal-inhibiting 
antibodies. 
In sharp contrast to the kind of variation displayed within the Mel-Gat-Chr 
group is  the sharp  qualitative difference between  this group  and the seven 
other viruses tested. Absorption of Mel, Gat, and Chr sera with PR8 invariably 
failed to remove all the antibodies  against these three agents and hence PR8 
virus lacked certain antigens present in these strains.  Absorption of these sera 
with still other viruses of these series gave similar results and it therefore seems 
probable  that there are antigens which are peculiar to the Mel-Gat-Chr group. 
One  may think of influenza  A viruses  as containing two general  classes of 
antigens,  the non-specific or group A and the strain-or type-specific antigens. 
In the illustration given above, it appears  that PR8 possessed all of the non- 
specific antigens present in strains Mel, Gat, and Chr, since it was capable of 
absorbing all cross-reacting antibody from their sera but it apparently contains 
some of the non-specific antigens in much reduced  amount since it took so 
much virus to completely remove the cross-reactions, roughly five to ten times 
the  amount necessary  to  absorb  the  sera  completely  with  the  homologous 
viruses. 
Cross-Relationships among Ten A  Strain~ Isolated between 1932 and 1947 
The experiments reported below are similar to those in the previous section 
but since they cover a wider range of strains the results offer a more compre- 
hensive view of the occurrence of specific antigens from 1932 until the present. 
The absorptions in the previous tests were carried out with a  single virus strain in order 
to find out ff PR8 actually contained all the antigens necessary for completely removing the 
crossing antibody. For the practical matter of producing specific sera with the least amount 
of absorbing virus, most sera were absorbed once or twice with PR8 and once with Mel. This 
combination usually removed most of the non-specific antibody and that which was left was 
taken out with the specific crossing strain. This proved to be more efficient than the use of a Test  Strains 
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Fz(;.  3.  Complete  cross-HI  test  between  tea  viruses and  t3eir andsera, both absorbed 
and u~absorbed. Dotted ]mes indicate serum  titer before and soft(]  areas after absorption. 
The fo]]ow;_ng absorptions were caz~ed out: Serum Sw with PR8 (2) and iV1e]. Serum WS with 
PRS, Me|, and Sw. Serum PR8 wit3 Mel an(] "Ta]. Serum Me], C~t, and Chr each wit~ PR8 
(5).  Serum Ta] wit3  PR8,  Me],  an(] NY-43.  Serum ,Ma.-4t with  1)R8,  1Vial, Chr,  and Ta]. 
Serum NY-43 wit~ PRS, Me], and TaJ. Serum FIV[ wit~ 1)1~.8  (2), 1V[e],  l~Z-~, and Sw. Each 
absorption was carrie(] out with 0.5 vo]. concentrate(] v;_rus per t  vol. undiluted serum. Nu- 
merals m  parentheses after name of a virus instate number of absorptions with t3at strain. 
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single absorbing strain. Sera against the ten selected strains were absorbed to the point where 
non-specific  antibody was no longer detectable and a complete  cross-HI test involving  all the 
viruses and the unabsorbed and absorbed sera was carried out. The results are shown graphi- 
cally in Fig. 3. 
The crossing antibody was reduced in each case to the point where it was not 
detectable at a  final dilution of 1:16.  It is of some interest to see how much 
homologous antibody was removed to accomplish this result.  With  sera Sw, 
WS, and FM-1, the lowering of homologous titer on absorption was small, the 
specific element accounting for 50 per cent or more of the original homologous 
titer. This is in line with the relatively high specificity shown by these strains 
with unabsorbed sera.  With most of the other strains,  the homologous titer 
after absorption was 12 to 25 per cent of the titer before absorption, except in 
the case of NY-43 serum in which it was much less. These percentages varied 
a  good deal, depending on the serum selected for absorption. 
As indicated above, Mel, Gat, and Chr formed one group of similar strains. 
Another though less unexpected group consisted of the 1941 and 1943 strains, 
which had shown only small antigenic differences by the usual methods. Each 
virus absorbed completely the antibody from the serum of the other and there- 
fore these two are representatives of the same strain type. Thus, among the 
ten strains studied there appeared to be seven strain types, of which six came 
from human epidemics. Sera were obtained against each of these types which 
after absorption reacted with the homologous strains in a titer usually in excess 
of 256 and at the same time failed to react with heterologous strains at 1:16. 
All the previous tests have been repeated in their entirety at least once with 
similar,  though  not  quantitatively identical  results.  The only difficulties in 
repetition were with Tal. This virus in general is a poor antigen and most anti- 
sera were of relatively low titer. Some Tal antisera were exhausted completely 
of antibody on absorption with PR8 virus, while others, like the one shown, 
retained low but specific titers.  Since Tal virus gave no crossing with other 
absorbed sera and since the positive results with Tal serum  seem more sig- 
nificant than the negative results, it is suggested that Tal is a prototype of a 
subgroup of the A viruses. 
The  Typing  of Influenza A  Strains  witk Specifically  Absorbed  Sera 
Since the production of absorbed antisera is slow and laborious, the extension 
of the foregoing system was most readily accomplished by attempting to classify 
other virus strains with absorbed sera of the seven strain types elucidated above. 
If other strains reacted specifically with single sera and without cross-reactions, 
it would greatly strengthen the conception of a true sort of qualitative specificity 
among influenza A viruses and at the same time gaps or omissions in the present 
series might be detected. 
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tests. Mel and Ala-41  were used as prototypes of their specific groups and a 
large array of viruses were tested against the seven type-specific sera at a dilu- 
tion of 1:16 final. When inhibition occurred, the HI level was titrated. All the 
absorbed sera used had homologous titers of at least 256 and usually much 
higher. 
The results, given in Table I, were encouraging since only one of 61 strains 
reacted with more than one absorbed serum, and while many strains were not 
inhibited by any serum, this may indicate only that some serological types were 
missing from the series.  No strain reacting with Sw serum was found and this 
was not unexpected since Sw was not of human origin. Likewise, no examples of 
PR8 and WS types were found and in this connection it should be pointed out 
that no other strains from the same epidemics were available. There were six 
strains which were inhibited by Mel serum and this includes examples isolated 
in England, Australia, and the United States in the years 1935 to 1937. Strain 
Patnode (No. 12) was the only strain which fell into the Talmey group but it 
reacted equally well with Ala-41 serum and is the sole example of a strain which 
reacted with  two  antisera.  This cross-reaction is being further  investigated. 
An example of the Ala-41 type first appeared in an Alaskan strain (No. 5) isolated 
in 1935 and others were found in the United States in 1936-37 (Nos. 11 and 13) 
and  in  Australia  in  1939  (No.  17).  In  numerous  examples from American, 
British,  and  Australian  outbreaks  from  1941  through  1944  the Ala41  type 
was the only one found, and then it all but disappeared recurring only once 
much  later  (1947-48)  in  what  appears  to  be an  exceptional case  (No.  42). 
The FM-1  type strains, as has been previously established, first were found in 
Australia in 1946, and remained as the only type in numerous epidemics, both 
here and elsewhere, up until early 1950. Three exceptions (Nos. 40, 41, and 43) 
will be mentioned below. The influenza outbreak of 1950-51 yielded A viruses 
which did not react with any absorbed serum and the possibilities of this being 
a new type are being explored. Three other strains, BH, NY-2, and TF, which 
were isolated in  the years  1935-37  also failed to react with  any antiserum, 
indicating the possibilities of the occurrence of still further types in that period. 
Special attention should be called to a few individual strains. Ala-41-E and 
Ala-41-M (Nos. 21 and 22) are two strains, each adapted to the chick embryo 
by different methods. The first was isolated in the amnlotic sac and adapted 
to allantoic growth, the other was passed initially in ferrets and then carried 
through forty mouse passages before being adapted  to the egg. Previous HI 
tests  established  that  the  two  strains  were  significantly different  from  one 
another in antigenic pattern (15), yet both were inhibited to approximately the 
same titer by absorbed Ala-41  antiserum and were unaffected by other sera. 
This illustrates an important point in  interpreting data  on  strain  differences 
since it indicates that mouse passage,  though it alters the antigenic pattern, 
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Another point of interest concerns the homogeneity of strains within an epi- 
demic. The  1941 epidemic of influenza A  in the United States was the first 
in which numerous strains were isolated that were antigenically homogenous 
(11) and a similar state of affairs by and large prevailed throughout subsequent 
outbreaks. There is now little doubt that in most epidemics there has been 
usually only one antigenic type or occasionally two (23) simultaneously present. 
There has been, however, a growing number of reports of limited outbreaks in 
recent years from which older types of A virus (PP,8,  for example) have been 
isolated. Isaacs and Andrewes (23) have taken the view that these exceptional 
isolations are examples of laboratory contamination and cite the fact that all 
such strains which they have examined were mouse-virulent on initial isolation. 
The mouse virulence, in their view, was evidence of contamination with a pre- 
viously mouse-adapted strain  and  the  resemblance to  PR8  was  due  to  the 
wide use of this strain in virus laboratories. It is beyond the scope of the present 
paper to discuss this problem in its entirety but strains L7-47 and L8-47  (Nos. 
40 and 41)  are examples of strain heterogeneity in the  1947 outbreak which 
are not so readily dismissed. These two strains were isolated by Sigel (20) in a 
school epidemic which was predominantly FM-1  in type  (Nos.  38  and 39). 
He found them (L7 and 8) to be serologically distinct from the FM-1 strains, 
even when cross-absorption was used. They are not virulent for mice (24) and 
the present tests confirm his findings since they fail to react not only with FM-1 
antisera, but with all the other types as well. Since they show no relationship 
to a wide variety of types, it seems permissible to conclude that they are not 
laboratory contaminants and that variations in strains may occur in epidemics, 
even though this behavior is exceptional. 
In Table I  it can be noted that there was considerable variation in the titer 
obtained with various strains against their type serum. This may be an indica- 
tion that these strains possess  the type antigens in varied form or in different 
amounts, but it seems at least equally likely that the variations may represent 
an alteration in the "avidity" of the strains for antibody. Hirst (11) first pro- 
posed this  term to  explain the fact that  some antisera inhibit heterologous 
strains to higher titer than the homologous one. The same phenomenon was 
encountered recently by Van der Veen and Mulder (25)  with their P  and Q 
viruses, the latter of which is inhibited in low titer by P  and Q sera but can 
stimulate the formation of antibodies which react  in high  titer with the  P 
variety. More extensive cross-testing would be necessary to prove that avidity 
is responsible for the variable titers which were found in the present work. 
DISCUSSION 
The results of absorption tests with influenza A viruses and their antisera 
indicate that the antigens of these agents can conveniently be divided into two 
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type-specific antigens which are peculiar to certain groups of strains. From ten 
strains which were studied seven distinct types were segregated on the basis of 
HI reactions with absorbed sera. Properly absorbed sera gave no cross-reactions 
among these types and permitted the classification of numerous A strains with 
very little ambiguity. When large strain differences were found between strains 
by the usual method With unabsorbed sera,  it was generally found that  this 
could be explained on the basis of a  difference in type antigens. Where small 
differences occurred, the strains  were often of the same  type and it seemed 
probable that they could be explained on the basis of purely quantitative varia- 
tions in the antigen content, especially the group antigen. Very limited experi- 
ments  showed that  the group antigens were similar in types PR8 and Mel, 
although  the difficulties of cross-absorption here again suggested quantitative 
variations in group antigens. 
A  great deal of the information about strain differences indicates that  the 
situation from 1933 to 1940 is widely at variance with what has prevailed since 
that time. Prior to 1940, a wide variety of strains were prevalent at one time, 
even in the same epidemic, while since 1940 the existence of a single variety of 
strain  throughout the world has been the dominant characteristic. Since the 
earlier work was  of necessity done with  mouse-adapted strains,  the natural 
but perhaps unwarranted assumption was made  (15)  that the earlier hetero- 
geneity was largely due to mouse adaptation. If the interpretation, suggested 
by the tests with Ala-41-E and Ala-41-M, is accepted, that mouse adaptation 
may induce small but not large changes in antigenic pattern and that it does 
not alter the virus type, then it follows that at least some of the heterogeneity 
seen prior to  1940 was in fact due to the concomitant existence of multiple 
types in the population. 
From this angle, it would appear that the first two A types (WS and PR8) dis- 
appeared in 1933 and  1934,  the length of time in which they were prevalent 
cannot be determined. Beginning in 1935 at least four and possibly more types 
occurred at the same time. One of these (Mel) was found between 1935 and 
1937. A second, Ala-41, was also found in this period and went on to become 
the only type existent between  1940  and  1944.  A  third type (Tal)  is so far 
monotypic and the existence of further types is as yet hypothetical, being based 
on the non-relationship of a  few strains  to any of the  type representatives. 
Experience since  1940  suggests the dominance of a  single type, Ala-41  until 
1944 and FM-1 from 1946 to 1950. The status of the 1950-51 strains is as yet 
unestablished.  If  this  interpretation is  accepted, it  is  apparent  that  the ex- 
perience since 1940 was not necessarily typical of the over-all epidemiological 
picture of influenza and the time may return when multiple types of virus may 
be prevalent at  one time.  Furthermore,  the  epidemic prevalence of a  given 
strain can be seen to be quite variable in duration, and in these results was as 
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The occurrence of one type at  a  time  since  1940  has  given an  excellent 
opportunity to study the occurrence of variation with a  type of virus from 
epidemic to epidemic. From 1941 to 1943 there was a  small antigenic change 
in the Ala41  type virus (12) and from 1947 through 1950 Hilleman (22)  and 
MagiU  (26) have shown small progressive changes in the FM-1  type of virus 
from year to year. From this rather restricted evidence, it seems that a virus 
type can change in minor ways from one appearance to the  next and  that 
these slow changes may be interrupted by major breaks with disappearance of 
old and appearance of new types. While there is not much evidence as to the 
importance of type changes in the problem of influenzal immunity, that which 
exists suggests that antigenic shifts within a  type have relatively little effect, 
as shown by the fact that immunization of man with FM-1 type virus of 1947 
protected individuals against the somewhat different variety of FM-1 infection 
seen in  1950  (27).  On  the  other hand  it  was  thoroughly established  that  a 
vaccine of the Ala-41 type offered no protection whatsoever against an epidemic 
due to FM-1 type virus (28). 
There are, of course, many problems in connection with the foregoing work 
which need further study. Among these are the Completion of the analysis of 
the available A viruses so that all strains may be included in one system. A 
similar program should be carried out with B  strains. Of greatest importance, 
however, is the extension of the present methods of study by the use of in vivo 
techniques in the hope of gaining some assessment of the relative importance of 
group-specific versus  type-specific antigens in the development of the immune 
state. Nothing has been done along these lines as yet. Although the importance 
of a  system such as has been proposed is in many respects not yet clear, a 
grouping of strains based on antigenic composition has proven to be a  sound 
approach to problems in other fields of microbiology. In the study of influenza 
it may well shed further light on the epidemiological processes at work. 
SUMMARY 
Rabbit antisera were prepared against  ten antigenically different influenza 
A strains. These sera were absorbed with one or more heterologous strains and 
in each case all the heterologous or crossing antibody was removed; the anti- 
bodies remaining after this treatment were specific for the immunizing strain 
or group of strains. 
On  the  basis  of reactions with  absorbed  sera,  the  strains  fell into  seven 
groups. 
Absorbed specific antisera of these groups were used  to  test  the  HI  titer 
against a large number of influenza A viruses. Most of the strains were inhibited 
by a  single serum,  a  few were inhibited by none of the sera,  and  only one 
strain was inhibited by two antisera. 
The grouping of strains by this method was less equivocal than classifi- GEORGE  K.  ItIRST  603 
cations based on previous tests.  When more fully developed,  this technique 
promises to be of interest and assistance in the study of influenza, especially 
from the epidemiological and prophylactic standpoints. 
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